These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 24034038

  • 1. Inhaled nitric oxide versus sodium nitroprusside for preoperative evaluation of pulmonary hypertension in heart transplant candidates.
    Pasero D, Rana NK, Bonato R, Ribezzo M, Ivaldi F, Ricci D, Grosso Marra W, Checco L, Lupo M, Boffini M, Rinaldi M.
    Transplant Proc; 2013 Sep; 45(7):2746-9. PubMed ID: 24034038
    [Abstract] [Full Text] [Related]

  • 2. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
    Kieler-Jensen N, Ricksten SE, Stenqvist O, Bergh CH, Lindelöv B, Wennmalm A, Waagstein F, Lundin S.
    J Heart Lung Transplant; 1994 Sep; 13(3):366-75. PubMed ID: 8061011
    [Abstract] [Full Text] [Related]

  • 3. Inhaled nitric oxide in the preoperative evaluation of pulmonary hypertension in heart transplant candidates.
    Mahajan A, Shabanie A, Varshney SM, Marijic J, Sopher MJ.
    J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):51-6. PubMed ID: 17289480
    [Abstract] [Full Text] [Related]

  • 4. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
    Fattouch K, Sbraga F, Bianco G, Speziale G, Gucciardo M, Sampognaro R, Ruvolo G.
    J Card Surg; 2005 Feb; 20(2):171-6. PubMed ID: 15725144
    [Abstract] [Full Text] [Related]

  • 5. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N, Lundin S, Ricksten SE.
    J Heart Lung Transplant; 1995 Feb; 14(3):436-43. PubMed ID: 7654728
    [Abstract] [Full Text] [Related]

  • 6. A comparison of inhaled nitric oxide with intravenous vasodilators in the assessment of pulmonary haemodynamics prior to cardiac transplantation.
    Pagano D, Townend JN, Horton R, Smith C, Clutton-Brock T, Bonser RS.
    Eur J Cardiothorac Surg; 1996 Feb; 10(12):1120-6. PubMed ID: 10369648
    [Abstract] [Full Text] [Related]

  • 7. Inhaled nitric oxide plus iloprost in the setting of post-left assist device right heart dysfunction.
    Antoniou T, Prokakis C, Athanasopoulos G, Thanopoulos A, Rellia P, Zarkalis D, Kogerakis N, Koletsis EN, Bairaktaris A.
    Ann Thorac Surg; 2012 Sep; 94(3):792-8. PubMed ID: 22727248
    [Abstract] [Full Text] [Related]

  • 8. Extracorporeal membrane oxygenation rescue therapy in a case of portopulmonary hypertension during liver transplantation: a case report.
    Stratta C, Lavezzo B, Ballaris MA, Panio A, Crucitti M, Andruetto P, Fanelli V, Grosso Marra W, Ranieri MV, Salizzoni M.
    Transplant Proc; 2013 Sep; 45(7):2774-5. PubMed ID: 24034045
    [Abstract] [Full Text] [Related]

  • 9. Inhaled nitric oxide through a noninvasive ventilation device to assess reversibility of pulmonary hypertension in selecting recipients for heart transplant.
    Fojón S, Fernández-González C, Sánchez-Andrade J, López-Pérez JM, Hermida LF, Rodríguez JA, Juffé A.
    Transplant Proc; 2005 Nov; 37(9):4028-30. PubMed ID: 16386617
    [Abstract] [Full Text] [Related]

  • 10. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM, Hare JM, Loh E, Gauthier DF, Colucci WS.
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
    von Scheidt W, Costard-Jaeckle A, Stempfle HU, Deng MC, Schwaab B, Haaff B, Naegele H, Mohacsi P, Trautnitz M, PROPHET Study Group.
    J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
    [Abstract] [Full Text] [Related]

  • 12. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
    Santini F, Casali G, Franchi G, Auriemma S, Lusini M, Barozzi L, Favaro A, Messina A, Mazzucco A.
    Int J Cardiol; 2005 Aug 18; 103(2):156-63. PubMed ID: 16080974
    [Abstract] [Full Text] [Related]

  • 13. Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates.
    Radovancevic B, Vrtovec B, Thomas CD, Croitoru M, Myers TJ, Radovancevic R, Khan T, Massin EK, Frazier OH.
    J Heart Lung Transplant; 2005 Jun 18; 24(6):690-5. PubMed ID: 15949728
    [Abstract] [Full Text] [Related]

  • 14. Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery.
    Schmid ER, Bürki C, Engel MH, Schmidlin D, Tornic M, Seifert B.
    Anesth Analg; 1999 Nov 18; 89(5):1108-15. PubMed ID: 10553820
    [Abstract] [Full Text] [Related]

  • 15. Effects of inhaled nitric oxide following lung transplantation.
    Yerebakan C, Ugurlucan M, Bayraktar S, Bethea BT, Conte JV.
    J Card Surg; 2009 Nov 18; 24(3):269-74. PubMed ID: 19438780
    [Abstract] [Full Text] [Related]

  • 16. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
    Khan TA, Schnickel G, Ross D, Bastani S, Laks H, Esmailian F, Marelli D, Beygui R, Shemin R, Watson L, Vartapetian I, Ardehali A.
    J Thorac Cardiovasc Surg; 2009 Dec 18; 138(6):1417-24. PubMed ID: 19931670
    [Abstract] [Full Text] [Related]

  • 17. Inhaled NO and sildenafil combination in cardiac surgery patients with out-of-proportion pulmonary hypertension: acute effects on postoperative gas exchange and hemodynamics.
    Matamis D, Pampori S, Papathanasiou A, Papakonstantinou P, Tsagourias M, Galiatsou E, Koulouras V, Nakos G.
    Circ Heart Fail; 2012 Jan 18; 5(1):47-53. PubMed ID: 22057829
    [Abstract] [Full Text] [Related]

  • 18. Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance.
    Sablotzki A, Hentschel T, Gruenig E, Schubert S, Friedrich I, Mühling J, Dehne MG, Czeslick E.
    Eur J Cardiothorac Surg; 2002 Nov 18; 22(5):746-52. PubMed ID: 12414041
    [Abstract] [Full Text] [Related]

  • 19. Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension.
    Sablotzki A, Czeslick E, Schubert S, Friedrich I, Mühling J, Dehne MG, Grond S, Hentschel T.
    Can J Anaesth; 2002 Dec 18; 49(10):1076-80. PubMed ID: 12477682
    [Abstract] [Full Text] [Related]

  • 20. Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease.
    Morris K, Beghetti M, Petros A, Adatia I, Bohn D.
    Crit Care Med; 2000 Aug 18; 28(8):2974-8. PubMed ID: 10966281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.